Drugs / Heptavalent Streptoccus pneumonia; Prevnar
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00488683 Background | Jul 2007 → May 2009 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heptavalent Streptoccus pneumonia; Prevnar | “Heptavalent Streptoccus pneumonia; Prevnar” NCT00488683 ↗ |
| Known as | PCV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00488683 ↗ |
| Route | Intramuscular | “IM injections of 3 doses of 0.5 mL each of PCV supplied in pre-filled syringe were administered” NCT00488683 ↗ |